Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desflurane vs Propofol for Recovery in Pituitary Adenoma Resection
NCT05088252Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Dec 2021
- Primary completion
- May 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised trial of desflurane in pituitary adenoma (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Time required of the Aldrete score reached 9 points after drug withdrawal. Started Dec 2021; status: completed.
02
Drugs
desflurane
03
Conditions
pituitary adenoma
Beyond the preview
Go deeper on NCT05088252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05088252.